Literature DB >> 1414756

[A case of retroperitoneal Castleman's disease associated with bladder tumor and a review of 59 cases in Japan].

H Morishita1, T Kobayashi, K Kunimi, T Amano, K Koshida, T Uchibayashi, H Hisazumi, K Naito.   

Abstract

We present a case of retroperitoneal Castleman's disease associated with bladder tumor. The patient was a 62-year-old man, who underwent partial cystectomy under a diagnosis of bladder tumor in 1989. Subsequently, recurrent bladder tumor was detected and he consulted the outpatient clinic at our University Hospital in November, 1990, at which time computerized tomography (CT) revealed a retroperitoneal tumor. From February, 1991 four courses of combined chemotherapy (methotrexate, vinblastine, pirarubicin, cisplatin) were administered for the tumor. The tumor reduction rate after the chemotherapy was 60% on CT, and retroperitoneal lymph node dissection and left nephroureterectomy were performed in July, 1991. Histological examination revealed Castleman's disease, hyaline-vascular type. Fifty-nine reported cases of retroperitoneal Castleman's disease in Japan are reviewed.

Entities:  

Mesh:

Year:  1992        PMID: 1414756

Source DB:  PubMed          Journal:  Hinyokika Kiyo        ISSN: 0018-1994


  3 in total

1.  Surgical management of abdominal and retroperitoneal Castleman's disease.

Authors:  Pascal Bucher; Gilles Chassot; Guillaume Zufferey; Frederic Ris; Olivier Huber; Philippe Morel
Journal:  World J Surg Oncol       Date:  2005-06-07       Impact factor: 2.754

2.  Retroperitoneal Castleman's disease with colon cancer. A rare association.

Authors:  César Gómez-Raposo; Manuel Nistal; Javier De Castro Carpeño; Grevelyn Sosa Rotundo; Cristóbal Belda-Iniesta; Enrique Casado; Manuel González Barón
Journal:  Clin Transl Oncol       Date:  2008-04       Impact factor: 3.405

3.  Acute myelogenous leukemia M5b developed during clinical remission of Castleman disease.

Authors:  Akira Tomonari; Naoki Shirafuji; Arinobu Tojo; Tohru Iseki; Jun Ooi; Itaru Komiya; Kenzaburo Tani; Shigetaka Asano
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.319

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.